The deal, which was first announced in March, is expected to provide average net payments of about $7 to more than 51,000 people with account balances in the pharmaceutical company’s 401(k) plan since June 2017, representing about 19.5% of their alleged losses.
- Judge David J. Hale granted final approval to the settlement and awarded class counsel nearly $250,000 in attorneys’ fees and expenses in an order issued Monday
- Hale, who sits in the US District Court for the Western ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
